Jing Song Wang
Chief Executive Officer presso HBM HOLDINGS LIMITED
Profilo
Founder of HBM Holdings Ltd., Jing Song Wang holds the position of Chairman & Chief Executive Officer for HBM Holdings Ltd., Chairman & Chief Executive Officer at Harbour BioMed (Shanghai) Co., Ltd.
(a subsidiary of HBM Holdings Ltd.), Chief Executive Officer at Hbm Suzhou Co. Ltd.
and Chief Executive Officer for Hbm Guangzhou.
He is also on the board of Xinjiang Baihuacun Pharam Tech Co., Ltd., Silicon INSITE, Inc., Frontage Holdings Corp.
and InSilico Medicine Cayman TopCo.
In his past career he occupied the position of Head-Research & Development at Sanofi (China) Investment Co. Ltd.
Jing Song Wang received a doctorate from China Pharmaceutical University, a graduate degree from Jilin University and a graduate degree from Xuzhou Medical University.
Posizioni attive di Jing Song Wang
Società | Posizione | Inizio |
---|---|---|
FRONTAGE HOLDINGS CORPORATION | Director/Board Member | - |
HBM HOLDINGS LIMITED | Chief Executive Officer | 20/07/2016 |
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Director/Board Member | 17/09/2021 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Chief Executive Officer | - |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Director/Board Member | 01/08/2016 |
Hbm Suzhou Co. Ltd. | Chief Executive Officer | - |
Hbm Guangzhou | Chief Executive Officer | - |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Director/Board Member | 01/06/2023 |
Precedenti posizioni note di Jing Song Wang
Società | Posizione | Fine |
---|---|---|
Sanofi (China) Investment Co. Ltd. | Corporate Officer/Principal | 01/12/2015 |
Formazione di Jing Song Wang
Jilin University | Graduate Degree |
China Pharmaceutical University | Doctorate Degree |
Xuzhou Medical University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Commercial Services |
FRONTAGE HOLDINGS CORPORATION | Health Technology |
HBM HOLDINGS LIMITED | Health Technology |
Aziende private | 6 |
---|---|
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Health Technology |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
Sanofi (China) Investment Co. Ltd. | |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
Hbm Suzhou Co. Ltd. | |
Hbm Guangzhou |